Alam Kamran's Form 4 filing
Taysha Gene Therapies, Inc. (TSHA) · filed Aug 25, 2023
- Accession no.
- 0001209191-23-047323
- Filed
- Aug 25, 2023
- Trade date
- Aug 24, 2023
- Filing delay
- 1 day
- Rule 10b5-1 plan
- Checked
This filing lists 1 non-derivative transaction and 0 derivative transactions. Open-market sales total $76.9K. It was filed 1 day after the trade.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Alam KamranCIK 0001793412 | Officer (Chief Financial Officer) |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Aug 24, 2023 | Common Stock | SSaleDisposed | −33,000 | $2.33 | −$76,890 | 258,042 | Direct |
Footnotes
Livermore does not store Form 4 footnotes. For price ranges, how indirect holdings are held and trading plan details, read the original on SEC EDGAR.